Literature DB >> 26295291

Detailed polymorphism study on cytomegalovirus DNA polymerase gene to reveal the most suitable genomic targets for quantitative Real-time PCR.

Onur Bilenoğlu1, Mustafa Altındiş, Ersoy Öz, Yeliz Yücel-Öz, Öykü İrigül-Sönmez, Can Bora Ünal.   

Abstract

The human cytomegalovirus (HCMV) is an important human pathogen primarily affecting immunocompromised patients, like transplant recipients or HIV- infected individuals. Early diagnosis of cytomegalovirus (CMV) infection in high-risk patients is essential in order to start preemptive treatments. pol (UL54) gene encoding for HCMV viral DNA polymerase is a well-defined target for HCMV detection in clinical samples and identifying most highly conserved regions for primer design remains crucial. Though real-time polymerase chain reaction (qPCR) is a rapid and sensitive method for HCMV detection, failure to detect some HCMV strains due to primer and target mismatches have led the researchers to explore more sensitive and reliable methods. Hence, to understand the broader diversity of the pol mutations in HCMV and to specify the most suitable region for primer-probe design to be used in qPCR assay, we studied both nucleotide and amino acid heterogeneities in 60 HCMV positive samples that were collected to represent national mutational prevalence of pol gene of HCMV in Turkey. The test was designed with a new set of primers- probe for HCMV detection and quantification based on the sequencing data which revealed the most conserved region on the pol gene. Statistical probit analysis was applied on qPCR studies which revealed a 95% detection limit of 100 copies/mL. In addition, linearity, reproducibility, and precision of the new test were assessed for diagnostic purposes.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26295291      PMCID: PMC4594323          DOI: 10.17305/bjbms.2015.494

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  19 in total

1.  Evaluation of CMV viral load using TaqMan CMV quantitative PCR and comparison with CMV antigenemia in heart and lung transplant recipients.

Authors:  M Guiver; A J Fox; K Mutton; N Mogulkoc; J Egan
Journal:  Transplantation       Date:  2001-06-15       Impact factor: 4.939

2.  Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus.

Authors:  Sunwen Chou; Nell S Lurain; Kenneth D Thompson; Richard C Miner; W Lawrence Drew
Journal:  J Infect Dis       Date:  2003-06-16       Impact factor: 5.226

3.  Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients.

Authors:  M D Pescovitz; J Rabkin; R M Merion; C V Paya; J Pirsch; R B Freeman; J O'Grady; C Robinson; Z To; K Wren; L Banken; W Buhles; F Brown
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

4.  Diagnostic consequences of cytomegalovirus glycoprotein B polymorphisms.

Authors:  Zdenek Novak; Nazma Chowdhury; Shannon A Ross; Sunil K Pati; Karen Fowler; Suresh B Boppana
Journal:  J Clin Microbiol       Date:  2011-06-08       Impact factor: 5.948

Review 5.  CMV: Prevention, Diagnosis and Therapy.

Authors:  C N Kotton
Journal:  Am J Transplant       Date:  2013-02       Impact factor: 8.086

6.  Acquisition of donor strains of cytomegalovirus by renal-transplant recipients.

Authors:  S W Chou
Journal:  N Engl J Med       Date:  1986-05-29       Impact factor: 91.245

Review 7.  Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis.

Authors:  P Chrisp; S P Clissold
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

8.  Mutations conferring foscarnet resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis.

Authors:  Adriana Weinberg; Douglas A Jabs; Sunwen Chou; Barbara K Martin; Nell S Lurain; Michael S Forman; Clyde Crumpacker
Journal:  J Infect Dis       Date:  2003-02-24       Impact factor: 5.226

Review 9.  Immunocompromised hosts: perspectives in the treatment and prophylaxis of cytomegalovirus disease in solid-organ transplant recipients.

Authors:  Gilberto Torres-Madriz; Helen W Boucher
Journal:  Clin Infect Dis       Date:  2008-09-01       Impact factor: 9.079

Review 10.  New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection.

Authors:  Sheila C Dollard; Scott D Grosse; Danielle S Ross
Journal:  Rev Med Virol       Date:  2007 Sep-Oct       Impact factor: 6.989

View more
  1 in total

1.  Joint association of carrying HLA-B*13:01 gene and human herpesvirus-6 with occupational trichloroethylene hypersensitivity syndrome.

Authors:  Dianpeng Wang; Dafeng Lin; Peimao Li; Huimin Liu; Yanhua Yang; Zhimin Zhang; Qiuyue Kong; Yanfang Zhang; Xianqing Huang
Journal:  Int Arch Occup Environ Health       Date:  2019-02-13       Impact factor: 2.851

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.